Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Tofacitinib treatment is used for teenagers with alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The "Danti Original Source" method can reverse androgenetic alopecia.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Minoxidil sulfate helps hair regrowth in alopecia areata by enhancing anti-inflammatory effects and reducing mitochondrial stress.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

The new X-ray technique allows for precise and non-destructive measurement of elements in hair, creating the first database of its kind for a specific ethnic group.

Follistatin helps hair growth and cycling, while activin prevents it.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

LC-OCT is a useful noninvasive tool for diagnosing and monitoring alopecia areata.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

The method produces finasteride with a 92% yield.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Baricitinib helps with early hair regrowth in people with alopecia areata.